pyrvinium has been researched along with Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aminzadeh-Gohari, S; Catalano, L; Feichtinger, RG; Kofler, B; Lang, R; Weber, DD | 1 |
| Liu, Y; Pan, J; Zheng, L | 1 |
2 other study(ies) available for pyrvinium and Melanoma
| Article | Year |
|---|---|
Targeting Mitochondria in Melanoma.
Topics: Anticarcinogenic Agents; Cell Line, Tumor; Cell Proliferation; Fibroblasts; Glycolysis; Humans; Melanoma; Mitochondria; Oxidative Phosphorylation; Oxidative Stress; Pyrvinium Compounds | 2020 |
Inhibitory effect of pyrvinium pamoate on uveal melanoma cells involves blocking of Wnt/β-catenin pathway.
Topics: Anthelmintics; beta Catenin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Glycogen Synthase Kinase 3 beta; Humans; Inhibitor of Apoptosis Proteins; Melanoma; Phosphorylation; Pyrvinium Compounds; Survivin; Uveal Neoplasms; Wnt Signaling Pathway; X-Linked Inhibitor of Apoptosis Protein | 2017 |